Alamar Biosciences, Inc. (ALMR) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Alamar Biosciences, Inc. (ALMR) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$27.96 MLiabilities$78.12 MCurrent assets$331.38 MNon-current liabilities$50.16 MAssets$390.98 MEquity$312.86 MGross equity(calculated)$516.30 MNon-current assets$59.59 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsShort-term investmentsInventoryAccounts receivablePrepaid expenses and other current assetsOperating lease right-of-use assetsProperty and equipment, netRestricted cashOther assets - noncurrentCapitalized software, netAccounts payableAccrued and other current liabilitiesShort-term operating lease liabilitiesLong-term operating lease liabilitiesTerm debtOther noncurrent liabilitiesAdditional paid-in capitalCommon stockCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossAccounts payableAccounts payable$13.79 MCurrent liabilitiesCurrent liabilities$27.96 MAccrued and other current liabilitiesAccrued and other current liabilities$11.89 MLiabilitiesLiabilities$78.12 MCurrent assetsCurrent assets$331.38 MShort-term operating lease liabilitiesShort-term operating lease liabilities$2.28 MCash and cash equivalentsCash and cash equivalents$132.97 MNon-current liabilitiesNon-current liabilities$50.16 MLong-term operating lease liabilitiesLong-term operating lease liabilities$39.18 MAssetsAssets$390.98 MEquityEquity$312.86 MTerm debtTerm debt$9.95 MShort-term investmentsShort-term investments$117.08 MOther noncurrent liabilitiesOther noncurrent liabilities$1.03 MGross equity (calculated)Gross equity(calculated)$516.30 MInventoryInventory$45.41 MAccounts receivableAccounts receivable$20.34 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$15.58 MOperating lease right-of-use assetsOperating lease right-of-use assets$35.80 MAdditional paid-in capitalAdditional paid-in capital$516.29 MNon-current assetsNon-current assets$59.59 MProperty and equipment, netProperty and equipment, net$13.36 MRestricted cashRestricted cash$6.25 MOther assets - noncurrentOther assets - noncurrent$2.58 MCapitalized software, netCapitalized software, net$1.61 MCommon stockCommon stock$7.00 KAccumulated deficitAccumulated deficit−$203.30 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$139.00 K
Chart details

Alamar Biosciences, Inc. (ALMR) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
390,975,000 US dollars
Current assets
331,382,000 US dollars
Non-current assets
59,593,000 US dollars
Liabilities
78,118,000 US dollars
Current liabilities
27,960,000 US dollars
Non-current liabilities
50,158,000 US dollars
Equity
312,857,000 US dollars
Cash and cash equivalents
132,969,000 US dollars
Short-term investments
117,083,000 US dollars
Inventory
45,409,000 US dollars
Accounts receivable
20,344,000 US dollars
Prepaid expenses and other current assets
15,577,000 US dollars
Operating lease right-of-use assets
35,798,000 US dollars
Property and equipment, net
13,358,000 US dollars
Restricted cash
6,254,000 US dollars
Other assets - noncurrent
2,578,000 US dollars
Capitalized software, net
1,605,000 US dollars
Accounts payable
13,790,000 US dollars
Accrued and other current liabilities
11,893,000 US dollars
Short-term operating lease liabilities
2,277,000 US dollars
Long-term operating lease liabilities
39,182,000 US dollars
Term debt
9,947,000 US dollars
Other noncurrent liabilities
1,029,000 US dollars
Additional paid-in capital
516,288,000 US dollars
Common stock
7,000 US dollars
Accumulated deficit
negative 203,299,000 US dollars
Accumulated other comprehensive loss
negative 139,000 US dollars
Gross equity (calculated)
516,295,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Alamar Biosciences, Inc. (ALMR) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!